Adverse Metabolic Changes May Accompany Switch From TDF- to TAF-containing Antiretroviral Therapy Adverse Metabolic Changes May Accompany Switch From TDF- to TAF-containing Antiretroviral Therapy

Replacing TDF with TAF in antiretroviral therapy regimens raises the risk of significant weight gain and worsening blood lipid levels in people living with HIV, the Swiss HIV Cohort Study team reports.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news